• Mashup Score: 0

    The Academy’s HIV-focused professional certifications are the first and only credentials offered domestically and internationally to physicians, nurse practitioners, physician assistants and pharmacists specializing in advanced level HIV care. The HIV Specialist™ (AAHIVS) credential is available to practicing frontline clinical providers, while the HIV Expert™ (AAHIVE) designation can be earned by non-practicing clinicians. The HIV Pharmacist™ (AAHIVP) certification is available to eligible HIV-specialized

    Tweet Tweets with this article
    • Apply to earn or renew your #HIVSpecialist™, #HIVPharmacist™, or #HIVExpert™ Credential today! Registration for the final testing period of 2023 closes October 18. Details and application: https://t.co/nWQcUaQaKH. #HIVCredentialed #TwitteRx #IDTwitter #PharmacistsDay https://t.co/tYBciHshd9

  • Mashup Score: 1

    Study findings suggest that patients be screened for vitamin D deficiency before starting SGLT2 inhibitor therapy, or they should simply be prescribed vitamin D supplements.

    Tweet Tweets with this article
    • Vitamin D deficiency appears to render people more vulnerable to canagliflozin's adverse effects on bone health, whereas vitamin D3 supplementation appears protective of individuals with vitamin D deficiency. #TwitteRx https://t.co/7VXihgvGoN https://t.co/1Se5ljq7uU

  • Mashup Score: 0

    Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical’s drug Vyvanse, which is expected to offset the ongoing shortage of the ADHD medicine in the United States.

    Tweet Tweets with this article
    • Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical's drug Vyvanse, which is expected to offset the ongoing shortage of the #ADHD medicine. #TwitteRx https://t.co/LLKZzg7vlB

  • Mashup Score: 1

    Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical’s drug Vyvanse, which is expected to offset the ongoing shortage of the ADHD medicine in the United States.

    Tweet Tweets with this article
    • Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical's drug Vyvanse, which is expected to offset the ongoing shortage of the #ADHD medicine. #TwitteRx #PsychTwitter https://t.co/hZbPjPn2Qi